Market Overview

Amended S-1 from Viking Therapeutics Shows Expecting IPO of 5M Shares in $10-12/Share Range

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News IPOs

 

Related Articles (VKTX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional